Human Microbiome Market
Global Human Microbiome Market Size, Share & Trends Analysis Report by Product Type (Probiotics, Prebiotics, Medical Foods, Drugs, and Others), by Disease (Cancer, Gastrointestinal Disorder, Infectious Diseases, Diabetes, and Others) and by Technology (Genomics, Proteomics, and Metabolomics) and Forecast 2019-2025
The global human microbiome market is growing at a significant CAGR of around 19.5% during the forecast period (2019-2025). The major factors that are primarily driving the growth of the market include the rising focus on human microbiome therapy, increasing government initiatives and funding for microbiome research and growing research activities for early disease diagnosis. In addition, the increasing government spending for promoting the microbiome research in numerous countries is expected to promote the growth of the market in the future years. For instance, one such initiative, taken by NIH, is the HMP which began in 2007 as an extension of the Human Genome Project. The project was initiated for enhancing the research on microbiomes in the US.
Moreover, the cost associated with the sequencing technologies has decreased in the past years; this is expected to be one of the prime reasons which are expected to promote the growth of the market during the forecast period. There are numerous market players collaborating AI with microbiome sequencing to promote studies on gut microbiomes. For instance, in 2018, Viome, Inc. has developed Vie, company’s artificial intelligence system, that uses data gathered from four sources including biological testing, expert knowledge, customer feedback, and scientific literature. However, lack of skilled labor will affect the global human microbiome market growth during the forecast period.
Segmental Outlook
The human microbiome market is classified on the basis of product type, disease, and technology. Based on product type, the market is segmented into probiotics, prebiotics, medical foods, drugs, and others. Based on disease, the market is segmented into cancer, gastrointestinal disorder, infectious diseases, diabetes, and others. Based on technology, the market is segmented into genomics, proteomics, and metabolomics.
Global Human Microbiome Market Share by Technology, 2018 (%)
Human microbiome significantly adopts genomics technology
Genomics technology is one of the major technologies used in human microbiome market. According to the National Center for Biotechnology Information (NCBI), the characterization and analysis of the human microbiome is significantly catalyzed by the advances in genomic technologies. Genomics includes an extensive and well-characterized collections of reference genomes, which indicates traits of the human disease. There are several projects announced by the governmental bodies in support of genomic research, which in turn, offers a growth to genomics technology in human microbiome market.
1000 Genomes Project is an effort that comprises genome sequencing of at least a thousand people from across the globe to develop the most comprehensive and medically relevant picture of human genetic variation. This initiative intends to make accessible genomic data easily from international research institutions. The major support for the project is offered by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), Wellcome Trust Sanger Institute in Hinxton, England, and the Beijing Genomics Institute, Shenzhen (BGI Shenzhen) in China.
Regional Outlook
The global human microbiome market is classified on the basis of geography, which includes North America, Europe, Asia-Pacific, and Rest of the World. The growth is attributed due to increasing government initiative and funding for the microbiome research. North American human microbiome market is driven by the significant contribution from the US, followed by Canada. The US government has invested significantly in these areas to promote the research on microbiomes and their impact on the biological processes. The US government has devised an Interagency Strategic Plan for Microbiome Research for the fiscal year 2018-2022 to understand the exact functioning of microbiomes in humans. The NIH invested $250 million in 2016 for microbiome research. Canadian institutes of health and research is the key institutes, which investing in the R&D of microbiomes study across North America.
Global Human Microbiome Market Growth, by Region 2019-2025
Market Players Outlook
The key players in the human microbiome market are contributing significantly by providing advanced technology-based products and through expanding their geographical presence across the globe. The key players operating in the global human microbiome market include Illumina Inc., Seres Therapeutics, Inc., Vedanta Biosciences, Inc., Novogene Corp., Qiagen NV, and Thermo Fisher Scientific Inc. These market players adopt various strategies such as product launch, partnerships, collaborations, merger, and acquisitions to sustain a strong position in the market. For instance, Seres Therapeutics, Inc. collaborated with AstraZeneca PLC in March 2019. The companies have planned to explore and test SER-401 in combination with its oncology assets.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global human microbiome market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Illumina Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Vedanta Biosciences, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Novogene Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Qiagen NV
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Thermo Fisher Scientific Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Human Microbiome Market by Product Type
5.1.1. Probiotics
5.1.2. Prebiotics
5.1.3. Medical Foods
5.1.4. Drugs
5.1.5. Others (Diagnostic Tests)
5.2. Global Human Microbiome Market by Disease
5.2.1. Cancer
5.2.2. Gastrointestinal Disorder
5.2.3. Infectious Diseases
5.2.4. Diabetes
5.2.5. Others (Neurological Disorder)
5.3. Global Human Microbiome Market by Technology
5.3.1. Genomics
5.3.2. Proteomics
5.3.3. Metabolomics
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 4D pharma PLC
7.2. BiomX Inc.
7.3. DuPont de Nemours, Inc.
7.4. Enterome SA
7.5. Evelo Biosciences, Inc.
7.6. Ferring International Center S.A.
7.7. Illumina Inc.
7.8. Kaleido Biosciences, Inc.
7.9. LNC Therapeutics
7.10. Molzym GmbH & Co. KG
7.11. Novogene Corp.
7.12. OptiBiotix Health PLC
7.13. Qiagen NV
7.14. Rebiotix Inc.
7.15. Ritter Pharmaceuticals, Inc.
7.16. Second Genome Inc.
7.17. Seres Therapeutics, Inc.
7.18. Thermo Fisher Scientific Inc.
7.19. uBiome Inc.
7.20. Vedanta Biosciences, Inc.
1. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
2. GLOBAL HUMAN MICROBIOME PROBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL HUMAN MICROBIOME PREBIOTICS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL HUMAN MICROBIOME MEDICAL FOODS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL HUMAN MICROBIOME DRUGS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL OTHER HUMAN MICROBIOME PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
8. GLOBAL HUMAN MICROBIOME FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL HUMAN MICROBIOME FOR GASTROINTESTINAL DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL HUMAN MICROBIOME FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL HUMAN MICROBIOME FOR DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL HUMAN MICROBIOME FOR OTHER DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
14. GLOBAL HUMAN MICROBIOME GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
15. GLOBAL HUMAN MICROBIOME PROTEOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
16. GLOBAL HUMAN MICROBIOME METABOLOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
17. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
18. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
19. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
20. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
21. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
22. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
23. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
24. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
25. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
26. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
27. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
28. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
29. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
30. REST OF THE WORLD HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
31. REST OF THE WORLD HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
32. REST OF THE WORLD HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
1. GLOBAL HUMAN MICROBIOME MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
2. GLOBAL HUMAN MICROBIOME MARKET SHARE BY DISEASE, 2018 VS 2025 (%)
3. GLOBAL HUMAN MICROBIOME MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
4. GLOBAL HUMAN MICROBIOME MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. US HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
6. CANADA HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
7. UK HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
9. GERMANY HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
10. ITALY HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
11. SPAIN HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
12. ROE HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
13. INDIA HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
14. CHINA HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
15. JAPAN HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
17. REST OF THE WORLD HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
